Innovative Antisense
Oligonucleotide Therapies

Image

Meet Secarna

BIO-Europe® 2019
Hamburg, GER
November 11 – 13, 2019

Deutsches Eigenkapitalforum 2019
Frankfurt/Main, GER
November 25 – 27, 2019
Presentation Venture Stage on Tuesday, Nov 26, 2 pm

About Secarna

Secarna is a new breed biopharmaceutical company based in Munich, Germany, We have developed a proprietary drug discovery platform, LNAplus™, for the next generation of antisense oligonucleotides.
Together with our partners in academia and industry, we have advanced multiple innovative antisense therapies into various stages of pre-clinical development in the areas of immuno-oncology, ophthalmology, immunology, fibrotic diseases (airways, liver, kidney), and anti-viral applications.

 

Image

Secarna

A new breed biopharmaceutical company
Find out more

Image

Technology

Antisense Oligonucleotides
Find out more

Image

Platform

Secarna’s LNAplus™ Discovery Platform
Find out more

Image

Pipeline

Secarna`s next generation ASO programs
Find out more

Image

Publications

More about antisense oligonucleotides
Find out more

Image

Partnering

Meaningfully structured alliances
Find out more